1. Home
  2. RDY vs HNI Comparison

RDY vs HNI Comparison

Compare RDY & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • HNI
  • Stock Information
  • Founded
  • RDY 1984
  • HNI 1944
  • Country
  • RDY India
  • HNI United States
  • Employees
  • RDY N/A
  • HNI N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • HNI Office Equipment/Supplies/Services
  • Sector
  • RDY Health Care
  • HNI Consumer Discretionary
  • Exchange
  • RDY Nasdaq
  • HNI Nasdaq
  • Market Cap
  • RDY 2.5B
  • HNI 2.3B
  • IPO Year
  • RDY N/A
  • HNI N/A
  • Fundamental
  • Price
  • RDY $13.35
  • HNI $46.61
  • Analyst Decision
  • RDY Buy
  • HNI Strong Buy
  • Analyst Count
  • RDY 1
  • HNI 1
  • Target Price
  • RDY $17.00
  • HNI $63.00
  • AVG Volume (30 Days)
  • RDY 1.8M
  • HNI 267.3K
  • Earning Date
  • RDY 01-23-2025
  • HNI 02-20-2025
  • Dividend Yield
  • RDY 3.60%
  • HNI 2.83%
  • EPS Growth
  • RDY 2.68
  • HNI 164.22
  • EPS
  • RDY 0.75
  • HNI 2.88
  • Revenue
  • RDY $3,637,607,642.00
  • HNI $2,526,400,000.00
  • Revenue This Year
  • RDY $17.23
  • HNI $5.42
  • Revenue Next Year
  • RDY $9.20
  • HNI $2.73
  • P/E Ratio
  • RDY $17.68
  • HNI $16.18
  • Revenue Growth
  • RDY 14.74
  • HNI 3.80
  • 52 Week Low
  • RDY $13.16
  • HNI $40.94
  • 52 Week High
  • RDY $16.89
  • HNI $58.42
  • Technical
  • Relative Strength Index (RSI)
  • RDY 33.41
  • HNI 36.37
  • Support Level
  • RDY $13.16
  • HNI $48.18
  • Resistance Level
  • RDY $13.46
  • HNI $50.15
  • Average True Range (ATR)
  • RDY 0.15
  • HNI 1.46
  • MACD
  • RDY -0.01
  • HNI -0.05
  • Stochastic Oscillator
  • RDY 21.02
  • HNI 18.21

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About HNI HNI Corporation

HNI Corp is a provider of office furniture and hearth products. The company generates the bulk of its revenue from its workplace furnishing, which consists of panel-based and freestanding furniture systems, seating, storage, tables, and architectural products. These products are sold through a national system of dealers, wholesalers, and office product distributors but also directly to end-user customers and federal, state, and local governments. Residential building products include a full array of gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and accessories. The company has operations in the United States, Canada, Mainland China, Hong Kong, India, Mexico, and Taiwan.

Share on Social Networks: